Bottromycin A2

    WARNING: This product is for research use only, not for human or veterinary use.

MedKoo CAT#: 463971

CAS#: 15005-62-6

Description: Bottromycin A2 is an antibiotic originally isolated from Streptomyces. It blocks the binding of aminoacyl-tRNA to the A site of the 50S ribosome, inhibiting protein synthesis. Bottromycin A2 is active against clinical isolates of methicillin-resistant Staphylococcus aureus (MRSA) and vancomycin-resistant Enterococci with MIC values of 1 and 0.5 µg/ml, respectively.

Chemical Structure

img
Bottromycin A2
CAS# 15005-62-6
Instruction

Theoretical Analysis

MedKoo Cat#: 463971
Name: Bottromycin A2
CAS#: 15005-62-6
Chemical Formula: C42H62N8O7S
Exact Mass: 822.45
Molecular Weight: 823.067
Elemental Analysis: C, 61.29; H, 7.59; N, 13.61; O, 13.61; S, 3.90

Price and Availability

This product is not in stock, which may be available by custom synthesis. For cost-effective reason, minimum order is 1g (price is usually high, lead time is 2~3 months, depending on the technical challenge). Quote less than 1g will not be provided. To request quote, please email to sales @medkoo.com or click below button.
Note: Price will be listed if it is available in the future.

Request quote for custom synthesis

Synonym: Bottromycin A2; Bottromycin-A2;

IUPAC/Chemical Name: methyl (R)-3-((2S,3S)-2-((S)-2-(((3S,6S,14R,14aS,E)-6-(tert-butyl)-3-isopropyl-14-methyl-1,4,10-trioxo-1,2,3,4,5,6,9,10,12,13,14,14a-dodecahydropyrrolo[1,2-a][1,4,7,10]tetraazacyclododecin-7-yl)amino)-3,3-dimethylbutanamido)-3-phenylbutanamido)-3-(thiazol-2-yl)propanoate

InChi Key: KSIZLOPUXFSFNR-XZNJZDOZSA-N

InChi Code: InChI=1S/C42H62N8O7S/c1-23(2)30-36(53)49-33(41(5,6)7)35(44-22-28(51)50-19-17-24(3)32(50)38(55)46-30)48-34(42(8,9)10)39(56)47-31(25(4)26-15-13-12-14-16-26)37(54)45-27(21-29(52)57-11)40-43-18-20-58-40/h12-16,18,20,23-25,27,30-34H,17,19,21-22H2,1-11H3,(H,44,48)(H,45,54)(H,46,55)(H,47,56)(H,49,53)/t24-,25+,27-,30+,31+,32+,33-,34-/m1/s1

SMILES Code: O=C1[C@]2(N(C(C/N=C(N[C@H](C(N[C@@H]([C@@H](C)C3=CC=CC=C3)C(N[C@H](CC(OC)=O)C4=NC=CS4)=O)=O)C(C)(C)C)\[C@H](C(C)(C)C)NC([C@H](C(C)C)N1)=O)=O)CC[C@H]2C)[H]

Appearance: Solid powder

Purity: >80% (or refer to the Certificate of Analysis)

Shipping Condition: Shipped under ambient temperature as non-hazardous chemical. This product is stable enough for a few weeks during ordinary shipping and time spent in Customs.

Storage Condition: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).

Solubility: Soluble in DMSO

Shelf Life: >2 years if stored properly

Drug Formulation: This drug may be formulated in DMSO

Stock Solution Storage: 0 - 4 C for short term (days to weeks), or -20 C for long term (months).

HS Tariff Code: 2934.99.9001

More Info:

Biological target:
In vitro activity:
In vivo activity:

Preparing Stock Solutions

The following data is based on the product molecular weight 823.07 Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.

Recalculate based on batch purity %
Concentration / Solvent Volume / Mass 1 mg 5 mg 10 mg
1 mM 1.15 mL 5.76 mL 11.51 mL
5 mM 0.23 mL 1.15 mL 2.3 mL
10 mM 0.12 mL 0.58 mL 1.15 mL
50 mM 0.02 mL 0.12 mL 0.23 mL
Formulation protocol:
In vitro protocol:
In vivo protocol:

Molarity Calculator

Calculate the mass, volume, or concentration required for a solution.
=
x
x
g/mol

*When preparing stock solutions always use the batch-specific molecular weight of the product found on the vial label and SDS / CoA (available online).

Reconstitution Calculator

The reconstitution calculator allows you to quickly calculate the volume of a reagent to reconstitute your vial. Simply enter the mass of reagent and the target concentration and the calculator will determine the rest.

=
÷

Dilution Calculator

Calculate the dilution required to prepare a stock solution.
x
=
x

1: Arn F, Frasson D, Kroslakova I, Rezzonico F, Pothier JF, Riedl R, Sievers M. Isolation and Identification of Actinomycetes Strains from Switzerland and their Biotechnological Potential. Chimia (Aarau). 2020 May 27;74(5):382-390. doi: 10.2533/chimia.2020.382. PMID: 32482215.

2: Sikandar A, Franz L, Melse O, Antes I, Koehnke J. Thiazoline-Specific Amidohydrolase PurAH Is the Gatekeeper of Bottromycin Biosynthesis. J Am Chem Soc. 2019 Jun 26;141(25):9748-9752. doi: 10.1021/jacs.8b12231. Epub 2019 Jun 13. PMID: 31192589.

3: Yamada T, Yagita M, Kobayashi Y, Sennari G, Shimamura H, Matsui H, Horimatsu Y, Hanaki H, Hirose T, O Mura S, Sunazuka T. Synthesis and Evaluation of Antibacterial Activity of Bottromycins. J Org Chem. 2018 Jul 6;83(13):7135-7149. doi: 10.1021/acs.joc.8b00045. Epub 2018 Apr 16. PMID: 29560726.

4: Yin M, Jiang M, Ren Z, Dong Y, Lu T. The complete genome sequence of Streptomyces autolyticus CGMCC 0516, the producer of geldanamycin, autolytimycin, reblastatin and elaiophylin. J Biotechnol. 2017 Jun 20;252:27-31. doi: 10.1016/j.jbiotec.2017.04.037. Epub 2017 May 2. PMID: 28472671.

5: Crone WJ, Vior NM, Santos-Aberturas J, Schmitz LG, Leeper FJ, Truman AW. Dissecting Bottromycin Biosynthesis Using Comparative Untargeted Metabolomics. Angew Chem Int Ed Engl. 2016 Aug 8;55(33):9639-43. doi: 10.1002/anie.201604304. Epub 2016 Jul 4. PMID: 27374993; PMCID: PMC5103208.

6: Gouda H, Kobayashi Y, Yamada T, Ideguchi T, Sugawara A, Hirose T, Omura S, Sunazuka T, Hirono S. Three-dimensional solution structure of bottromycin A2: a potent antibiotic active against methicillin-resistant Staphylococcus aureus and vancomycin-resistant Enterococci. Chem Pharm Bull (Tokyo). 2012;60(2):169-71. doi: 10.1248/cpb.60.169. PMID: 22293474.

7: Park SB, Lee IA, Suh JW, Kim JG, Lee CH. Screening and identification of antimicrobial compounds from Streptomyces bottropensis suppressing rice bacterial blight. J Microbiol Biotechnol. 2011 Dec;21(12):1236-42. doi: 10.4014/jmb.1106.06047. PMID: 22210608.

8: Kobayashi Y, Ichioka M, Hirose T, Nagai K, Matsumoto A, Matsui H, Hanaki H, Masuma R, Takahashi Y, Omura S, Sunazuka T. Bottromycin derivatives: efficient chemical modifications of the ester moiety and evaluation of anti-MRSA and anti- VRE activities. Bioorg Med Chem Lett. 2010 Oct 15;20(20):6116-20. doi: 10.1016/j.bmcl.2010.08.037. Epub 2010 Aug 18. PMID: 20833545.

9: Shimamura H, Gouda H, Nagai K, Hirose T, Ichioka M, Furuya Y, Kobayashi Y, Hirono S, Sunazuka T, Omura S. Structure determination and total synthesis of bottromycin A2: a potent antibiotic against MRSA and VRE. Angew Chem Int Ed Engl. 2009;48(5):914-7. doi: 10.1002/anie.200804138. PMID: 19115340.

10: Kaneda M. Studies on bottromycins. I. 1H and 13C NMR assignments of bottromycin A2, the main component of the complex. J Antibiot (Tokyo). 1992 May;45(5):792-6. doi: 10.7164/antibiotics.45.792. PMID: 1624382.

11: Sowa S, Masumi N, Inouye Y, Nakamura S, Takesue Y, Yokoyama T. Susceptibility of methicillin-resistant Staphylococcus aureus clinical isolates to various antimicrobial agents. Hiroshima J Med Sci. 1991 Dec;40(4):137-44. PMID: 1797744.

12: Singh SK, Gurusiddaiah S. Production, purification, and characterization of chandramycin, a polypeptide antibiotic from Streptomyces lydicus. Antimicrob Agents Chemother. 1984 Sep;26(3):394-400. doi: 10.1128/aac.26.3.394. PMID: 6548890; PMCID: PMC176177.

13: Schipper D. The revised structure of bottromycin A2. J Antibiot (Tokyo). 1983 Aug;36(8):1076-7. doi: 10.7164/antibiotics.36.1076. PMID: 6630058.

14: Otaka T, Kaji A. Mode of action of bottromycin A2: effect of bottromycin A2 on polysomes. FEBS Lett. 1983 Mar 7;153(1):53-9. doi: 10.1016/0014-5793(83)80118-5. PMID: 6337880.

15: Otaka T, Kaji A. Mode of action of bottromycin A2: effect on peptide bond formation. FEBS Lett. 1981 Jan 26;123(2):173-6. doi: 10.1016/0014-5793(81)80280-3. PMID: 7014241.

16: Liao YL. Studies on the new cell line TT-I: viral susceptibility and chromosomal changes related to mycoplasma contamination. Zhonghua Min Guo Wei Sheng Wu Xue Za Zhi. 1976 Dec;9(3-4):37-44. PMID: 1037533.

17: Takahashi Y, Naganawa H, Takita T, Umezawa H, Nakamura S. The revised structure of bottromycin A2. J Antibiot (Tokyo). 1976 Oct;29(10):1120-3. doi: 10.7164/antibiotics.29.1120. PMID: 994331.

18: Otaka T, Kaji A. Mode of action of bottromycin A2. Release of aminoacyl- or peptidyl-tRNA from ribosomes. J Biol Chem. 1976 Apr 25;251(8):2299-306. PMID: 770464.

19: Kinoshita T, Tanaka N. On the site of action of bottromycin A2. J Antibiot (Tokyo). 1970 Jun;23(6):311-2. doi: 10.7164/antibiotics.23.311. PMID: 5458308.

20: Lin YC, Kinoshita T, Tanak N. Mechanism of protein synthesis inhibition by bottromycin A2: studies with puromycin. J Antibiot (Tokyo). 1968 Aug;21(8):471-6. doi: 10.7164/antibiotics.21.471. PMID: 4884807.